Herve Hoppenot
Insider
- 2025
- Jun 10, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Herve Hoppenot files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pablo J. Cagnoni - $14.10M in INCY purchases and sales in the last 12 months
- Harold Bernstein - $7.44M in MAZE purchases and sales in the last 12 months
- Steven H. Stein - $6.27M in INCY purchases and sales in the last 12 months
- Jason V. Coloma - $6.19M in MAZE purchases and sales in the last 12 months
- Patrick A. Mayes - $6.01M in INCY purchases and sales in the last 12 months
- Atul Dandekar - $2.27M in MAZE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Herve Hoppenot?
Herve Hoppenot is a corporate insider of Maze Therapeutics, Inc. (MAZE). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Herve Hoppenot last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 6 filings going back to 2025.
Has Herve Hoppenot been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($19.77M) across all tracked filings.